BioNTech Q3 Profit Down; Lifts FY22 COVID-19 Vaccine Revenue View
7/11 13:10
(RTTNews) - German biotechnology company BioNTech SE reported Monday sharply lower profit in its third quarter reflecting weak revenues. Looking ahead, BioNTech has raised the lower end of its fiscal 2022 COVID-19 vaccine revenue estimate....